South Korean vaccine maker SK Bioscience Co. said Monday it has secured a US$31.3 million deal from the Pan American Health Organization (PAHO) to supply chickenpox vaccines to Latin American countries.

SK Bioscience said it has recently delivered its first batch of shipments of SKY Varicella, the company´s chickenpox vaccine introduced in 2018, to Central and South American countries through PAHO.